118 related articles for article (PubMed ID: 6387212)
21. Cefaclor in the treatment of susceptible infections in infants and children.
Rodriguez WJ; Ross S; Schwartz R; Goldenberg R; Khan W
Postgrad Med J; 1979; 55 Suppl 4():35-8. PubMed ID: 548941
[TBL] [Abstract][Full Text] [Related]
22. [Pharmacokinetic and clinical studies of cefteram pivoxil granule in the pediatric field].
Motohiro T; Yoshinaga Y; Oda K; Aramaki M; Kawakami A; Tanaka K; Koga T; Tomita S; Sakata Y; Yamashita F
Jpn J Antibiot; 1989 Sep; 42(9):2023-61. PubMed ID: 2810762
[TBL] [Abstract][Full Text] [Related]
23. [A double-blind comparative study on the efficacy of S6472, cefaclor, in the treatment of bacterial bronchitis].
Oshima S; Yokoyama Y; Kikuiri T; Murakami T; Nishihara H; Shimizu T; Abe M; Kurihara Y; Itoh C; Takeuchi K
Jpn J Antibiot; 1986 Oct; 39(10):2726-53. PubMed ID: 3543432
[TBL] [Abstract][Full Text] [Related]
24. In vivo antibacterial activity of FK482, a new orally active cephalosporin.
Mine Y; Yokota Y; Wakai Y; Kamimura T; Tawara S; Shibayama F; Kikuchi H; Kuwahara S
J Antibiot (Tokyo); 1988 Dec; 41(12):1888-95. PubMed ID: 3209480
[TBL] [Abstract][Full Text] [Related]
25. [Fundamental and clinical studies of S 6472 (sustained release preparation of cefaclor) in the pediatric field].
Sugita M; Toyonaga Y; Nakamura H; Kurosu Y; Hori M
Jpn J Antibiot; 1985 Sep; 38(9):2444-52. PubMed ID: 3908736
[TBL] [Abstract][Full Text] [Related]
26. [Some investigations on cefadroxil dry syrup (author's transl)].
Nakazawa S; Sato H; Niino K; Nakazawa S; Suzuki H; Iwasaki A; Hirama Y; Narita A; Chikaoka H; Yamaguchi T
Jpn J Antibiot; 1981 Feb; 34(2):171-9. PubMed ID: 7253197
[TBL] [Abstract][Full Text] [Related]
27. Serum and sputum levels of cefaclor.
Simon C; Gatzemeier U
Postgrad Med J; 1979; 55 Suppl 4():30-4. PubMed ID: 548940
[TBL] [Abstract][Full Text] [Related]
28. [Phase I clinical studies of S6472 (sustained release preparations of cefaclor)].
Ohtomo M; Ito M; Iida M; Yasuda M; Sonoyama T; Matsuda S
Jpn J Antibiot; 1985 Mar; 38(3):822-33. PubMed ID: 4032714
[TBL] [Abstract][Full Text] [Related]
29. [Basic and clinical studies on S-1108 in pediatric field].
Motohiro T; Handa S; Yamada S; Oki S; Yoshinaga Y; Aramaki M; Oda K; Sakata Y; Kato H; Yamashita F
Jpn J Antibiot; 1993 Dec; 46(12):1122-44. PubMed ID: 8107277
[TBL] [Abstract][Full Text] [Related]
30. [Pharmacokinetic, bacteriological and clinical studies of SY5555 in the pediatric field].
Motohiro T; Handa S; Yamada S; Oki S; Yoshinaga Y; Oda K; Sakata Y; Kato H; Yamashita F; Imai S
Jpn J Antibiot; 1995 Feb; 48(2):238-60. PubMed ID: 7745814
[TBL] [Abstract][Full Text] [Related]
31. [Clinical studies of S6472 in otorhinolaryngologic infections].
Baba S; Kinoshita H; Mori Y; Suzuki K; Ohyama M; Katsuta K; Furuta S; Ohno I; Noboru T; Yamamoto M
Jpn J Antibiot; 1985 Jul; 38(7):1750-60. PubMed ID: 4068219
[TBL] [Abstract][Full Text] [Related]
32. [Effect of cefaclor in urinary tract infections (2)].
Kajikawa H; Hosokawa S; Kameoka H; Nishimoto N; Miyoshi S; Iwao N; Mizutani S
Jpn J Antibiot; 1984 Aug; 37(8):1453-69. PubMed ID: 6502932
[TBL] [Abstract][Full Text] [Related]
33. In vitro and in vivo antibacterial activity of KT3777, a new orally active carbacephem.
Sato K; Okachi R; Matsukuma I; Mochida K; Hirata T
J Antibiot (Tokyo); 1989 Dec; 42(12):1844-53. PubMed ID: 2621166
[TBL] [Abstract][Full Text] [Related]
34. [A double-blind comparative study of S 6472 (a long-acting cefaclor) versus a conventional cefaclor preparation in complicated urinary tract infections].
Arakawa S; Takagi S; Matsumoto O; Kamidono S; Hirooka K; Hamami G; Matsumoto H; Saito H; Umezu K; Ishigami J
Jpn J Antibiot; 1990 Nov; 43(11):1873-92. PubMed ID: 2287055
[TBL] [Abstract][Full Text] [Related]
35. [Pharmacological and clinical studies on the long acting cefaclor (S6472)].
Fujimoto M; Sakai K; Ueda T; Doi S; Sasaki T; Morimoto Y; Sawada A; Masada A
Jpn J Antibiot; 1985 Mar; 38(3):849-57. PubMed ID: 3897612
[TBL] [Abstract][Full Text] [Related]
36. Biliary excretion of cefaclor. Experimental and clinical study.
Brogard JM; Pinget M; Comte F; Adloff M; Lavillaureix J
Chemotherapy; 1982; 28(3):189-99. PubMed ID: 7094660
[TBL] [Abstract][Full Text] [Related]
37. [Absorption and excretion studies of S6472 (sustained release preparations of cefaclor)].
Tateno M; Ito M; Iida M; Yasuda M; Sonoyama T; Matsuda S
Jpn J Antibiot; 1985 Mar; 38(3):834-48. PubMed ID: 4032715
[TBL] [Abstract][Full Text] [Related]
38. [Clinical examination of S 6472 (sustained release preparations of cefaclor on chronic respiratory tract infection].
Hayashi I; Ohnuma K
Jpn J Antibiot; 1988 Sep; 41(9):1313-8. PubMed ID: 3241330
[TBL] [Abstract][Full Text] [Related]
39. [Laboratory and clinical studies on cefteram pivoxil in the field of pediatrics].
Hayakawa F; Kuno K; Ogawa A; Nakao Y; Takeuchi H; Ando Y; Kito O
Jpn J Antibiot; 1989 Aug; 42(8):1849-59. PubMed ID: 2810748
[TBL] [Abstract][Full Text] [Related]
40. [Cefaclor dosage change with renal dysfunction].
Usuda Y; Sekine O
Jpn J Antibiot; 1985 Apr; 38(4):1141-6. PubMed ID: 4032725
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
